|
Audience: This activity is intended for
healthcare professionals practicing in managed care environments.
This activity is supported by an
educational grant from Teva
PLEASE CLICK HERE TO VIEW PRESENTATION
PLEASE CLICK HERE FOR POST TEST AND
EVALUATION
Instructions for CME/CEU: View the presentation, answer the
post test, complete the evaluation form and submit to
keads@namcp.org. You will
have the option on the post test/evaluation page to submit your
forms electronically or by faxing them to Katie Eads at
804-747-5316.
Summary
Multiple
sclerosis, as with any chronic disease, can be managed better when
diagnosed early. Early detection and treatment has an impact on
quality of life and disability status. The speaker will discuss the
benefits to the patient and payer regarding early detection and
treatment.
Objectives
-
Discuss the benefit of early
detection and treatment
-
Recognize the economic value of
early stage treatment
-
Evaluate the impact on the
patient’s quality of life with early treatment
|
Faculty: |
Ronald S. Murray, MD, FAAN,
Director, MS Clinic of Colorado Lone Tree, Colorado
|
| |
|
|
Disclosure:
|
Dr. Murray serves on the
speakers bureau for Biogen IDEC, EMD Serono, and Teva
Neuroscience. He serves as a consultant to Bayer Health
Care and Teva Neuroscience and was principal
investigator for Teva Neuroscience. |
Accreditation & Designation
The National Association of Managed
Care Physicians (NAMCP) is accredited by the Accreditation Council
for Continuing Medical Education to sponsor continuing medical
education for physicians. NAMCP designates this activity for a
maximum of 1 AMA PRA Category I creditsTM. Each physician should
claim credit commensurate with the extent of their participation in
the activity.
The American Association of Managed Care Nurses (AAMCN) has been
approved as a provider of continuing education by the Virginia
Nurses Association (VNA) VNA is accredited as an approver of
continuing education in nursing by the American Nurses Credentialing
Center’s Commission on Accreditation. Nurses who complete this
activity will be awarded 1.0 contact hours.
This activity has been approved by the American Board of Managed
Care Nursing for 1.0 contact hours toward CMCN recertification
requirements.
This activity is
supported by an educational grant from Teva
|